Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 4/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 7/20 | 0.33 |
| ▸ | ANO1 | Q5XXA6 | 2/20 | 0.33 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3063569 | 1.00 | FFAR1 (0.44) | FFAR1HPGDCD274ANO1MRGPRX4 | |
| SCHEMBL13222719 | 0.90 | FFAR1 (0.36) | FFAR1HPGDCD274FFAR4SCN3A | |
| SCHEMBL3053045 | 0.83 | FFAR1 (0.44) | FFAR1HPGDPOLB | |
| SCHEMBL13222684 | 0.83 | FFAR1 (0.44) | FFAR1HPGDPOLB | |
| SCHEMBL18940278 | 0.82 | FFAR1 (0.41) | FFAR1HPGDFFAR4SCN3APOLB | |
| SCHEMBL18940277 | 0.77 | FFAR1 (0.42) | FFAR1HPGDANO1FFAR4SCN3A | |
| SCHEMBL18940272 | 0.77 | FFAR1 (0.46) | FFAR1SCN3A | |
| SCHEMBL18940279 | 0.77 | FFAR1 (0.46) | FFAR1SCN3A | |
| SCHEMBL9903728 | 0.75 | SMN1; SMN2 (0.38) | FFAR1HPGDPOLB | |
| SCHEMBL29423934 | 0.74 | FFAR1 (0.35) | FFAR1HPGDFFAR4POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2215068-B1 | ANTIDIABETIC TRICYCLIC COMPOUNDS | MERCK SHARP & DOHME (US) | 2012-06-13 | — | — | EP | disclosed |